PILOT
831175
XINGANJIANG
873167
Beijing Highlander Digital Technology
300065
4
Hangzhou Gaoxin Materials Technology
300478
5
Shijihengtong Technology
301428
US Stock MarketDetailed Quotes
SLXN Silexion Therapeutics
- 1.080
- -0.190-14.96%
Close Feb 14 16:00 ET
- 1.090
- +0.010+0.93%
Post 20:01 ET
9.09MMarket Cap-0.06P/E (TTM)
1.277High1.020Low1.60MVolume1.250Open1.270Pre Close1.87MTurnover30.65%Turnover RatioLossP/E (Static)8.41MShares122.01852wk High-1.99P/B5.65MFloat Cap0.57552wk Low--Dividend TTM5.23MShs Float122.013Historical High--Div YieldTTM20.20%Amplitude0.575Historical Low1.163Avg Price1Lot Size
About Silexion Therapeutics Company
Silexion Therapeutics Corp. engages in the discovery and development of treatments for KRAS-driven cancers. The company is headquartered in Modiin, Israel.
Company Profile
SymbolSLXN
Company NameSilexion Therapeutics
Listing DateApr 9, 2021
CEOMr. Ilan Hadar
MarketNASDAQ
Address12 Abba Hillel Road
CityRamat-Gan
ProvinceTel Aviv
CountryIsrael
Zip Code5250606
Phone972-8-628-6005
Websitehttps://www.silexion.com
Company Executives
- Name
- Position
- Salary
- Ilan Hadar
- Chairman of the Board and Prospective Chief Executive Officer
- 253.61K
- Mirit Horenshtein Hadar
- Executive Vice President, Finance Affairs and Prospective Chief Financial Officer
- 26.24K
- Dr. Mitchell Shirvan
- Chief Scientific and Development Officer
- 206.80K
- Shlomo Noy
- Independent Director
- --
- Dror J. Abramov
- Independent Director
- --
- Avner Lushi
- Independent Director
- --
- Professor Amnon Peled, PhD
- Independent Director
- --
- Ruth Alon
- Independent Director
- --
- Ilan Levin
- Independent Director
- --
Trending Stocks
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio?
Moo Live
Jan 30 03:25
FOMC Press Conference, January 29, 2025